Search

Search Constraints

You searched for: Author/Creator Pohlman, Brad

Search Results

1. A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma. Issue 3 (4th March 2018)

2. A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma. (17th November 2014)

3. A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma. (17th November 2014)

4. Body mass index does not impact hematopoietic progenitor cell mobilization for autologous hematopoietic cell transplantation. Issue 6 (5th August 2019)

6. Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL). Issue 2 (1st February 2018)

7. Co-expression of MYC and BCL2 predicts poorer outcomes for relapsed/refractory diffuse large B-cell lymphoma with R-ICE and intent to transplant. (April 2018)

8. Early infectious complications after autologous hematopoietic cell transplantation for multiple myeloma. Issue 4 (1st June 2019)

9. Early stage, bulky Hodgkin lymphoma patients have a favorable outcome when treated with or without consolidative radiotherapy: potential role of PET scan in treatment planning. (13th July 2016)